← Back to front page
United States · Financial press · Barron's

This Biotech Stock Is Up 291% From Its IPO Price. It’s On Pace for a Record Closing High.

Published by Barron's · United States 11 h ago
This Biotech Stock Is Up 291% From Its IPO Price. It’s On Pace for a Record Closing High.
Barron's

Detailed summary

CG Oncology stock is on pace for a record closing high after ‘best case’ Phase 3 trial results for its bladder cancer treatment.

Read the full article on Barron's Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.barrons.com)

Also worth reading